Trials / Completed
CompletedNCT04937335
Craniopharyngioma With Tumoral Hemorrhage
Clinical Features and Risk Factors of Craniopharyngioma With Tumoral Hemorrhage
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 185 (actual)
- Sponsor
- Tongji Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Clinical data of 185 consecutive patients receiving resective operation with a pathological diagnosis of craniopharyngioma in our hospital between January 2013 and February 2021 were collected. Among these patients, 18 of them were recognized as craniopharyngioma with tumoral hemorrhage during the operation.
Detailed description
For each case, age, gender, smoking status, alcohol intake, past history, symptoms, blood pressure, blood cell count, blood biochemical tests, coagulation tests, hormone tests, radiological results, surgical treatment and the outcome at discharge were collected. The first test result after admission and before the operation was taken for the items of blood tests with multiple times in the analysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | intratumoral hemorrhage | Patients who were recognized as craniopharyngioma pathologically with tumoral hemorrhage observed during the operation were enrolled in the hemorrhage group. |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2021-02-01
- Completion
- 2021-02-01
- First posted
- 2021-06-24
- Last updated
- 2021-06-24
Source: ClinicalTrials.gov record NCT04937335. Inclusion in this directory is not an endorsement.